Cosmo Bio USA Suppliers


Worldwide
Cosmo Bio Co. Ltd. 
Home Algae (except Taiwan)
4BioDx (except Europe)
Yeastern Biotech
Cell Engineering Technologies 

North America only
Serumwerk
(Former Axis-Shield by Abbott
)
BQCkit
Ubiquigent

USA only
Cusabio 
Cusag
Koma Biotech
Larodan

USA Mexico and South America
Atlas Antibodies

About Cosmo Bio USA Suppliers:

Cell Engineering Technologies 

 

cet-5.png
cet-6.png

Product Line-up
       

                Human Recombinant Growth Factors & Cytokines
                Human Cell Lines
                Cell Culture Media

Supplier Name: Cell Engineering Technologies 
Supplier Location: USA
Founding Date: 2000
Distributed by Cosmo Bio USA Since: 2024
Supplier Website: https://celleng-tech.com/
CBU Supplier Code (cat. no. prefix): CET- 

About Cell Engineering Technologies

Cellular Engineering Technologies, Inc. (CET) provides optimized reagents and human cell lines that address the technical and clinical challenges of developing next-generation cell therapies and regenerative medicines. We offer native, human recombinant growth factors and cytokines designed to generate maximum cellular response and bioavailability. Our portfolio of human somatic stem cells and induced pluripotent stem cells, programmed using our patented virus and oncogene-free methods, produce the safest and most scalable starting cell line for your research and manufacturing needs. We also leverage our human protein expression models to create custom protein and peptide sequences. Contact one of our application scientists today to discuss how our bioproduction and cell line engineering expertise can accelerate your drug discovery or IND-enabling activities.


Publications That Cite CET Products:

Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells.
Chu, KA et al. | International Journal of Molecular Sciences 2023 APR.

Development of hydrogel-based composite scaffolds containing eggshell particles for bone regeneration applications.
Calvert, ND et al. | Journal of Biomedical Materials Research 2023 SEP

Exosomes derived from human adipose-derived stem cells alleviate hepatic ischemia-reperfusion (I/R) injury through the miR-183/ALOX5 axis.
Gong, Y et al. | FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 2023 MAR.

Texturization of polycrystalline titanium surfaces after low-energy ion-beam irradiation: Impact on biocompatibility
Garcia, M;Gago, R;Arroyo-Hernández, M;de Laorden, E;Iglesias, M;Esteban-Mendoza, D;Cuerno, R;Rickards, J; | Surface and Coatings Technology 2023

Naïve pluripotent-like characteristics of non-tumorigenic Muse cells isolated from human amniotic membrane
Ogawa, E;Oguma, Y;Kushida, Y;Wakao, S;Okawa, K;Dezawa, M; | Scientific reports 2022

Decellularized liver hydrogel enhances cell engraftment in orthotopic hepatocyte transplantation by promoting cell-cell interaction and angiogenesis.
Udagawa, D et al. | Research Square 2023 MAY.

Relationship between clock gene expression and CYP2C19 and CYP3A4 with benzodiazepines.
Tani, N et al. | Human & Experimental Toxicology 2023 APR.

Hydroxyapatite Nanocoating on Calcium Peroxide Microparticles for Sustained Oxygen Release
Tomioka, D et al. | Chemistry of Materials 2023

Studio preclinico di allograft bioingegnerizzati da diaframma umano decellularizzato per la rigenerazione del muscolo scheletrico. Patella
Patella, A et al. | Thesis 2022 JAN.

Effect of methamphetamine on clock genes and drug-metabolizing enzyme expression.
Tani, N et al. | Human & Experimental Toxicology 2022 AUG.

Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice.
Yudintceva, N et al. | Bioengineering 2022 NOV.

Effect of Metformin on Human Mesenchymal Stem Cells
Boyd, AM et al. | Thesis 2022 JAN.